IPO, Venture Global

Citadel's Giacchi on Venture Global's IPO
Pete Giacchi, Citadel Securities, joins 'Money Movers' to discuss Venture Global's initial public offering, the biggest IPO since July 2024.
LNG exporter Venture Global raises $1.75 bln in US IPO
Liquefied natural gas exporter Venture Global said on Thursday it had raised $1.75 billion, marking the first big initial public offering of President Donald Trump's second term as investors bet on his plan to boost U.
Venture Global Slashes IPO Price Range by More Than 40%
Venture Global Inc. slashed the marketed range for its initial public offering, bringing the potential valuation well below its $110 billion target.
US energy group Venture Global notches up $60bn valuation in IPO
US energy group Venture Global has been valued at just above $60bn in its initial public offering, marking a climbdown from a much loftier target of more than $100bn. The company priced its IPO at $25 a share,
Venture Global aims for $64 billion valuation at debut in test for energy IPOs
Venture Global's shares were indicated to open up to 6% above their offer price in their debut on the New York Stock Exchange on Friday, giving the LNG exporter a potential valuation of $64.11 billion.
Venture Global LNG Raises $1.75 Billion in IPO Amid Adjusted Valuation
Venture Global LNG has successfully raised $1.75 billion through its U.S. IPO after pricing 70 million shares at $25 each. The offering was adjusted from an initial plan of 50 million shares priced at $40 to $46 to
LNG pure-play Venture Global's IPO tests appetite for energy stocks under Trump administration
"The Trump administration has made very clear they support growing LNG exports," Venture CEO Mike Sable told CNBC in an ...
IPO market comeback: How recent major US listings fared
The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...
3FPX, ARM : IPO Rebound In 2025? Here's What's Fueling The Boom,...
The year 2025 is expected to see a resurgence of IPOs due to policy changes, monetary easing, and a favorable business ...
Trump Partner Builds $1 Billion Stake From India Real Estate IPO
When Donald Trump’s real estate business wanted to break into the Indian market in 2012, it turned to Atul Chordia and his ...
FierceBiotech3h
‘A really rational IPO environment’: What does it takes for a biotech to go public now?
After what many considered a “slow” year for IPOs, January has ushered in a string of biotechs filing to go public. But 2024 ...
Dorf-Ketal Chemicals India files for $580 million IPO, claim draft papers
The IPO consists of fresh issue of shares worth up to 15 billion rupees, while existing shareholder Menon Family Holdings ...
Odyssey Therapeutics Begins IPO Rollout
Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...
FierceBiotech8h
Obesity biotech Aardvark eyes IPO as Ascentage makes $126M Nasdaq debut
The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...
news.crunchbase3d
Preparing For The Bell: Governance Essentials To IPO Success
Achieving IPO readiness goes beyond executing on the IPO transaction itself. In this guest commentary Nithya B. Das of ...
Ascentage Pharma’s US Shares Climb After $126 Million IPO
Shares of Ascentage Pharma Group International rose as much as 4% in the Chinese biopharmaceutical company’s US trading debut ...